Related Experiment Video
Updated: Jul 17, 2026

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
Why have early investigational therapies of obsessive-compulsive disorder failed to materialise?
Donatella Marazziti1, Liliana Dell'Osso
1University of Pisa, Dipartimento di Medicina Clinica e Sperimentale, Section of Psichiatry , Via Roma 67, 56100 Pisa , Italy +39 050 2219768 ; +39 050 2219787 ; dmarazzi@psico.med.unipi.it.
Abstract:
The mid-1980s brought about a revolution in the way in which clinicians approached the treatment of obsessive-compulsive disorder (OCD) pharmacologically. Indeed, clinicians adopted the use of selective serotonin (5-HT) re-uptake inhibitors, as treatment options, when it was demonstrated that OCD patients responded specifically to drugs enhancing 5-HT functioning in approximately 60% of all cases. Evidence to suggest a role for serotonergic compounds in OCD was further elucidated by increasing evidence in the following years. Since then, a number of different compounds that more or less directly modulate the 5-HT system have been proposed, although other therapeutic targets have also been considered. Unfortunately, despite our advancement in the understanding of this disorder, several of the treatment proposals never reached the clinic, staying at mere suggestion or not receiving sufficient development. The aim of this paper is to reflect and comment on the possible reasons that might have led to neglect or discarding these drugs that might have been effective in treating OCD.
Insights
Selective serotonin re-uptake inhibitors revolutionized obsessive-compulsive disorder (OCD) treatment. This paper explores why other potentially effective OCD drugs were overlooked or underdeveloped.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Selective serotonin re-uptake inhibitors (SSRIs) transformed obsessive-compulsive disorder (OCD) pharmacotherapy in the mid-1980s.
- OCD patients demonstrated significant response rates (approx. 60%) to drugs enhancing serotonin (5-HT) neurotransmission.
- Subsequent research identified numerous compounds modulating the 5-HT system and explored alternative therapeutic targets for OCD.
Purpose of the Study:
- To analyze the reasons behind the neglect or abandonment of potentially effective pharmacological treatments for OCD.
- To reflect on the development pipeline of novel OCD therapeutics.
Main Methods:
- Literature review and critical analysis of proposed OCD treatments.
- Examination of historical trends in psychopharmacology research for OCD.
Main Results:
- Despite advancements in understanding OCD, several promising drug candidates failed to reach clinical application.
- Reasons for discarding potential treatments remain largely unexamined.
Conclusions:
- Further investigation is needed to understand why effective OCD treatments may have been prematurely discarded.
- Understanding these past failures can inform future drug development for obsessive-compulsive disorder.
More Related Videos
09:14Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
11:17Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Related Concept Videos
Drug Discovery: Overview
Preclinical Development: Overview
Obsessive-Compulsive Disorder
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...